IBA Dosimetry is a prominent player in the health care, manufacturing, medical devices, and pharmaceutical industries. Founded in 1974, the company is headquartered in Schwarzenbruck near Nuremberg, Germany, with subsidiaries in Herndon VA, USA, and Bejing, China. Its innovative high-end quality assurance solutions and imaging markers for radiation diagnostics and therapy aim to improve cancer care by delivering maximum efficiency and minimized errors for better outcomes. The company offers a full range of innovative solutions, including instruments and software, to enable medical physicists and radiologists to perform necessary quality assurance and calibration procedures. Precision is fundamental in radiation therapy, and IBA Dosimetry strives to ensure accurate diagnosis and efficient treatment outcomes while prioritizing patient safety. As the world’s N° 1 dosimetry solution provider in installed systems and in bringing innovations into hospitals, the company aims to be a leading total dosimetry partner for the community. For more information, you can visit their website: IMPRINT and PRIVACY STATEMENT.
There is no investment information
No recent news or press coverage available for IBA Dosimetry.